Literature DB >> 10296580

Inherent risk and market acceptance of generic drug products.

N V Carroll, A P Wolfgang.   

Abstract

The results of a national survey of pharmacists indicate that generic substitutes are less likely to be used for drugs with higher inherent risk. Drugs used to treat chronic disease conditions are viewed as high risk products. Those used to treat symptoms are considered low risk products.

Entities:  

Mesh：

Year:  1989        PMID： 10296580

Source DB:  PubMed          Journal:  J Health Care Mark        ISSN： 0737-3252


  5 in total

1.  Impact of consumer fees on drug utilisation.

Authors:  D G Smith; D M Kirking
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

2.  Comparative potency and dissolution performance of internationally available piroxicam products.

Authors:  J A Barone
Journal:  Pharmacoeconomics       Date:  1992       Impact factor: 4.981

3.  Knowledge, attitudes, and practices of community pharmacists on generic medicines in Qatar.

Authors:  Ahmed Awaisu; Nadir Kheir; Mohamed Izham Mohamed Ibrahim; Maguy El-Hajj; Huda Hazi; Nada Khudair; Raja Barazi
Journal:  Int J Clin Pharm       Date:  2014-02-15

Review 4.  The generic alternative in schizophrenia: opportunity or threat?

Authors:  Philippe Nuss; David Taylor; Marc De Hert; Martina Hummer
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

5.  Pharmaceutical Evaluation of Cefuroxime Axetil Tablets Available in Drug Market of Pakistan.

Authors:  F Israr; Z A Mahmood; F Hassan; S M F Hasan
Journal:  Indian J Pharm Sci       Date:  2016 Jan-Feb       Impact factor: 0.975
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.